Amylyx Pharmaceuticals, Inc. AMLX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.54B.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s market capitalization?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported market capitalization of $1.54B in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s market capitalization increased by 389.9% year-over-year, from $313.65M to $1.54B.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s market capitalization?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s market capitalization has grown at a -18.1% compound annual growth rate (CAGR), from $2.42B to $1.33B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.